Siemens expands AI-driven pharma software portfolio, integrating Dotmatics’ platform to connect drug research, development, ...

Siemens has agreed to acquire Dotmatics for $5.1 billion, a combination the companies said would use artificial intelligence to speed up development cycles and help make breakthroughs in the life ...

Dotmatics®, a leader in R&D scientific software connecting science, data, and decision-making, and Databricks, the Data and AI company, today announced a strategic partnership to advance ...

Dotmatics centralizes data from disparate sources — applications, databases, and lab instruments — enabling AI algorithms to analyze this information at an unprecedented scale.

Dotmatics, a leader in R&D scientific software connecting science, data, and decision-making, today announced a significant minority investment in BioGlyph, a startup biotech software company that ...

Siemens AG said on Wednesday it will acquire U.S.-based Dotmatics for $5.1 billion from private equity firm Insight Partners to strengthen its Life Sciences portfolio.

Dotmatics is a global team of more than 800 people dedicated to supporting its customers in over 180 countries. The company's principal office is in Boston , with 13 offices and R&D teams located ...

As Dotmatics continues to innovate, the company aims to push the boundaries of drug discovery through integrated bioinformatics and AI-driven research. Daily insights on business use cases with VB ...

Siemens SIE-0.21%decrease; red down pointing triangle has agreed to acquire Dotmatics for $5.1 billion, a combination the companies said would use artificial intelligence to speed up development ...